September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 13-19 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, the goal of this campaign is to help spread awareness among both the…

Continue Reading September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

New Meniere’s Disease Treatment Has FDA Approval to Advance to a Phase III Trial

Sound Pharmaceuticals announced the first-ever Phase III clinical trial protocol for Meniere’s disease to be approved by the FDA. Meniere’s disease (MD) is a neurotologic disorder that involves tinnitus (ringing…

Continue Reading New Meniere’s Disease Treatment Has FDA Approval to Advance to a Phase III Trial
Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease
RobinHiggins / Pixabay

Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease

  According to a Town News press release, Sound Pharmaceuticals, a biopharmaceutical company based in Seattle, received FDA approval for their Phase 3 clinical trial on SPI-1005. The trial, STOPMD-3,…

Continue Reading Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease